Abstract A11: A comprehensive and integrative omic analysis of multiply relapsed refractory pediatric pre-B cell acute lymphoblastic leukemia predicts response to CD19 CAR T-cell therapy
Katherine E. Masih(National Institutes of Health), Javed Khan(Kent State University), Rimas J. Orentas(Capital Caring), Michael C. Kelly(National Cancer Institute), Serifat Adebola(National Cancer Institute), Grégoire Altan‐Bonnet(National Cancer Institute), Ashley Wilson(Center for Infectious Disease Research), Zachary Rae(National Institutes of Health), Jun S. Wei(Center for Cancer Research), Abdalla Abdelmaksoud(National Cancer Institute), Justin Lack(Office of Extramural Research), Benjamin Z. Stanton(Nationwide Children's Hospital), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Rebecca Gardner(Seattle Children's Hospital), Berkley E. Gryder(University School), Xinyu Wen(National Institutes of Health), Chaoyu Wang(Chongqing University), Michael C. Jensen(Seattle Children's Hospital)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k